Selected research
Market Outlook & Growth Opportunities
Global Custom Oligo Synthesis Market Outlook and Growth Opportunities 2026
Market perspective
The global Custom Oligo Synthesis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Custom Oligo Synthesis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Custom Oligo Synthesis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Custom Oligo Synthesis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Custom Oligo Synthesis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Custom Oligo Synthesis market include Wuhan GeneCreate Biological Engineering, General Biol, Atantares, Beyotime, Thermo Fisher Scientific, Merck, Genscript, Guangzhou RiboBio and Tsingke, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Custom Oligo Synthesis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Custom Oligo Synthesis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Custom Oligo Synthesis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Custom Oligo Synthesis market.
Custom Oligo Synthesis Segment by Company
Wuhan GeneCreate Biological Engineering
General Biol
Atantares
Beyotime
Thermo Fisher Scientific
Merck
Genscript
Guangzhou RiboBio
Tsingke
Abace Biotechnology
TriLink BioTechnologies
Synbio Technologies
Macrogen
Integrated DNA Technologies (IDT)
Eurogentec
Cusabio
BBI Life Sciences
Azenta Life Sciences
Aurigene Pharmaceutical Services
Custom Oligo Synthesis Segment by Type
Common Primer Synthesis
Modified Primer Synthesis
Custom Oligo Synthesis Segment by Application
Biotech Company
Academic Scientific Research Institution
Custom Oligo Synthesis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Custom Oligo Synthesis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Custom Oligo Synthesis key companies, revenue, market share, and recent developments.
3. To split the Custom Oligo Synthesis breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Custom Oligo Synthesis market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Custom Oligo Synthesis significant trends, drivers, influence factors in global and regions.
6. To analyze Custom Oligo Synthesis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Oligo Synthesis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom Oligo Synthesis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Oligo Synthesis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Custom Oligo Synthesis industry.
Chapter 3: Detailed analysis of Custom Oligo Synthesis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Custom Oligo Synthesis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Custom Oligo Synthesis in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Common Primer Synthesis
- Modified Primer Synthesis
Applications
- Biotech Company
- Academic Scientific Research Institution
Companies covered
- Wuhan GeneCreate Biological Engineering
- General Biol
- Atantares
- Beyotime
- Thermo Fisher Scientific
- Merck
- Genscript
- Guangzhou RiboBio
- Tsingke
- Abace Biotechnology
- TriLink BioTechnologies
- Synbio Technologies
- Macrogen
- Integrated DNA Technologies (IDT)
- Eurogentec
- Cusabio
- BBI Life Sciences
- Azenta Life Sciences
- Aurigene Pharmaceutical Services
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Custom Oligo Synthesis Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Custom Oligo Synthesis Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Custom Oligo Synthesis Market Dynamics
- 2.1 Custom Oligo Synthesis Industry Trends
- 2.2 Custom Oligo Synthesis Industry Drivers
- 2.3 Custom Oligo Synthesis Industry Opportunities and Challenges
- 2.4 Custom Oligo Synthesis Industry Restraints
3 Custom Oligo Synthesis Market by Company
- 3.1 Global Custom Oligo Synthesis Company Revenue Ranking in 2025
- 3.2 Global Custom Oligo Synthesis Revenue by Company (2021-2026)
- 3.3 Global Custom Oligo Synthesis Company Ranking (2024-2026)
- 3.4 Global Custom Oligo Synthesis Company Manufacturing Base and Headquarters
- 3.5 Global Custom Oligo Synthesis Company Product Type and Application
- 3.6 Global Custom Oligo Synthesis Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Custom Oligo Synthesis Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Custom Oligo Synthesis Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Custom Oligo Synthesis Market by Type
- 4.1 Custom Oligo Synthesis Type Introduction
- 4.1.1 Common Primer Synthesis
- 4.1.2 Modified Primer Synthesis
- 4.2 Global Custom Oligo Synthesis Sales Value by Type
- 4.2.1 Global Custom Oligo Synthesis Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Custom Oligo Synthesis Sales Value by Type (2021-2032)
- 4.2.3 Global Custom Oligo Synthesis Sales Value Share by Type (2021-2032)
5 Custom Oligo Synthesis Market by Application
- 5.1 Custom Oligo Synthesis Application Introduction
- 5.1.1 Biotech Company
- 5.1.2 Academic Scientific Research Institution
- 5.2 Global Custom Oligo Synthesis Sales Value by Application
- 5.2.1 Global Custom Oligo Synthesis Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Custom Oligo Synthesis Sales Value by Application (2021-2032)
- 5.2.3 Global Custom Oligo Synthesis Sales Value Share by Application (2021-2032)
6 Custom Oligo Synthesis Regional Value Analysis
- 6.1 Global Custom Oligo Synthesis Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Custom Oligo Synthesis Sales Value by Region (2021-2032)
- 6.2.1 Global Custom Oligo Synthesis Sales Value by Region: 2021-2026
- 6.2.2 Global Custom Oligo Synthesis Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Custom Oligo Synthesis Sales Value (2021-2032)
- 6.3.2 North America Custom Oligo Synthesis Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Custom Oligo Synthesis Sales Value (2021-2032)
- 6.4.2 Europe Custom Oligo Synthesis Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Custom Oligo Synthesis Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Custom Oligo Synthesis Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Custom Oligo Synthesis Sales Value (2021-2032)
- 6.6.2 South America Custom Oligo Synthesis Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Custom Oligo Synthesis Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Custom Oligo Synthesis Sales Value Share by Country, 2025 VS 2032
7 Custom Oligo Synthesis Country-level Value Analysis
- 7.1 Global Custom Oligo Synthesis Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Custom Oligo Synthesis Sales Value by Country (2021-2032)
- 7.2.1 Global Custom Oligo Synthesis Sales Value by Country (2021-2026)
- 7.2.2 Global Custom Oligo Synthesis Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.7.2 France Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.14.2 China Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.17.2 India Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Custom Oligo Synthesis Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Custom Oligo Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Custom Oligo Synthesis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Wuhan GeneCreate Biological Engineering
- 8.1.1 Wuhan GeneCreate Biological Engineering Company Information
- 8.1.2 Wuhan GeneCreate Biological Engineering Business Overview
- 8.1.3 Wuhan GeneCreate Biological Engineering Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
- 8.1.4 Wuhan GeneCreate Biological Engineering Custom Oligo Synthesis Product Portfolio
- 8.1.5 Wuhan GeneCreate Biological Engineering Recent Developments
- 8.2 General Biol
- 8.2.1 General Biol Company Information
- 8.2.2 General Biol Business Overview
- 8.2.3 General Biol Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
- 8.2.4 General Biol Custom Oligo Synthesis Product Portfolio
- 8.2.5 General Biol Recent Developments
- 8.3 Atantares
- 8.3.1 Atantares Company Information
- 8.3.2 Atantares Business Overview
- 8.3.3 Atantares Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
- 8.3.4 Atantares Custom Oligo Synthesis Product Portfolio
- 8.3.5 Atantares Recent Developments
- 8.4 Beyotime
- 8.4.1 Beyotime Company Information
- 8.4.2 Beyotime Business Overview
- 8.4.3 Beyotime Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
- 8.4.4 Beyotime Custom Oligo Synthesis Product Portfolio
- 8.4.5 Beyotime Recent Developments
- 8.5 Thermo Fisher Scientific
- 8.5.1 Thermo Fisher Scientific Company Information
- 8.5.2 Thermo Fisher Scientific Business Overview
- 8.5.3 Thermo Fisher Scientific Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
- 8.5.4 Thermo Fisher Scientific Custom Oligo Synthesis Product Portfolio
- 8.5.5 Thermo Fisher Scientific Recent Developments
- 8.6 Merck
- 8.6.1 Merck Company Information
- 8.6.2 Merck Business Overview
- 8.6.3 Merck Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
- 8.6.4 Merck Custom Oligo Synthesis Product Portfolio
- 8.6.5 Merck Recent Developments
- 8.7 Genscript
- 8.7.1 Genscript Company Information
- 8.7.2 Genscript Business Overview
- 8.7.3 Genscript Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
- 8.7.4 Genscript Custom Oligo Synthesis Product Portfolio
- 8.7.5 Genscript Recent Developments
- 8.8 Guangzhou RiboBio
- 8.8.1 Guangzhou RiboBio Company Information
- 8.8.2 Guangzhou RiboBio Business Overview
- 8.8.3 Guangzhou RiboBio Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
- 8.8.4 Guangzhou RiboBio Custom Oligo Synthesis Product Portfolio
- 8.8.5 Guangzhou RiboBio Recent Developments
- 8.9 Tsingke
- 8.9.1 Tsingke Company Information
- 8.9.2 Tsingke Business Overview
- 8.9.3 Tsingke Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
- 8.9.4 Tsingke Custom Oligo Synthesis Product Portfolio
- 8.9.5 Tsingke Recent Developments
- 8.10 Abace Biotechnology
- 8.10.1 Abace Biotechnology Company Information
- 8.10.2 Abace Biotechnology Business Overview
- 8.10.3 Abace Biotechnology Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
- 8.10.4 Abace Biotechnology Custom Oligo Synthesis Product Portfolio
- 8.10.5 Abace Biotechnology Recent Developments
- 8.11 TriLink BioTechnologies
- 8.11.1 TriLink BioTechnologies Company Information
- 8.11.2 TriLink BioTechnologies Business Overview
- 8.11.3 TriLink BioTechnologies Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
- 8.11.4 TriLink BioTechnologies Custom Oligo Synthesis Product Portfolio
- 8.11.5 TriLink BioTechnologies Recent Developments
- 8.12 Synbio Technologies
- 8.12.1 Synbio Technologies Company Information
- 8.12.2 Synbio Technologies Business Overview
- 8.12.3 Synbio Technologies Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
- 8.12.4 Synbio Technologies Custom Oligo Synthesis Product Portfolio
- 8.12.5 Synbio Technologies Recent Developments
- 8.13 Macrogen
- 8.13.1 Macrogen Company Information
- 8.13.2 Macrogen Business Overview
- 8.13.3 Macrogen Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
- 8.13.4 Macrogen Custom Oligo Synthesis Product Portfolio
- 8.13.5 Macrogen Recent Developments
- 8.14 Integrated DNA Technologies (IDT)
- 8.14.1 Integrated DNA Technologies (IDT) Company Information
- 8.14.2 Integrated DNA Technologies (IDT) Business Overview
- 8.14.3 Integrated DNA Technologies (IDT) Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
- 8.14.4 Integrated DNA Technologies (IDT) Custom Oligo Synthesis Product Portfolio
- 8.14.5 Integrated DNA Technologies (IDT) Recent Developments
- 8.15 Eurogentec
- 8.15.1 Eurogentec Company Information
- 8.15.2 Eurogentec Business Overview
- 8.15.3 Eurogentec Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
- 8.15.4 Eurogentec Custom Oligo Synthesis Product Portfolio
- 8.15.5 Eurogentec Recent Developments
- 8.16 Cusabio
- 8.16.1 Cusabio Company Information
- 8.16.2 Cusabio Business Overview
- 8.16.3 Cusabio Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
- 8.16.4 Cusabio Custom Oligo Synthesis Product Portfolio
- 8.16.5 Cusabio Recent Developments
- 8.17 BBI Life Sciences
- 8.17.1 BBI Life Sciences Company Information
- 8.17.2 BBI Life Sciences Business Overview
- 8.17.3 BBI Life Sciences Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
- 8.17.4 BBI Life Sciences Custom Oligo Synthesis Product Portfolio
- 8.17.5 BBI Life Sciences Recent Developments
- 8.18 Azenta Life Sciences
- 8.18.1 Azenta Life Sciences Company Information
- 8.18.2 Azenta Life Sciences Business Overview
- 8.18.3 Azenta Life Sciences Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
- 8.18.4 Azenta Life Sciences Custom Oligo Synthesis Product Portfolio
- 8.18.5 Azenta Life Sciences Recent Developments
- 8.19 Aurigene Pharmaceutical Services
- 8.19.1 Aurigene Pharmaceutical Services Company Information
- 8.19.2 Aurigene Pharmaceutical Services Business Overview
- 8.19.3 Aurigene Pharmaceutical Services Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
- 8.19.4 Aurigene Pharmaceutical Services Custom Oligo Synthesis Product Portfolio
- 8.19.5 Aurigene Pharmaceutical Services Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst